1. Sun, Xiujie, Wu, Bogang, Chiang, Huai-Chin, An, Zhiqiang, Li, Rong. 2021. Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion. In Nature, 599, 673-678. doi:10.1038/s41586-021-04057-2. https://pubmed.ncbi.nlm.nih.gov/34732895/
2. Wu, Donglin, Ding, Zihui, Lu, Tao, Zhang, Feng, Lu, Shuai. 2024. DDR1-targeted therapies: current limitations and future potential. In Drug discovery today, 29, 103975. doi:10.1016/j.drudis.2024.103975. https://pubmed.ncbi.nlm.nih.gov/38580164/
3. Su, Hua, Yang, Fei, Fu, Rao, Sun, Beicheng, Karin, Michael. 2022. Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome. In Nature, 610, 366-372. doi:10.1038/s41586-022-05169-z. https://pubmed.ncbi.nlm.nih.gov/36198801/
4. Xiong, Yi-Xiao, Zhang, Xiao-Chao, Zhu, Jing-Han, Zhang, Zhan-Guo, Zhang, Wan-Guang. 2023. Collagen I-DDR1 signaling promotes hepatocellular carcinoma cell stemness via Hippo signaling repression. In Cell death and differentiation, 30, 1648-1665. doi:10.1038/s41418-023-01166-5. https://pubmed.ncbi.nlm.nih.gov/37117273/
5. Borza, Corina M, Bolas, Gema, Bock, Fabian, Zent, Roy, Pozzi, Ambra. 2022. DDR1 contributes to kidney inflammation and fibrosis by promoting the phosphorylation of BCR and STAT3. In JCI insight, 7, . doi:10.1172/jci.insight.150887. https://pubmed.ncbi.nlm.nih.gov/34941574/